Bio-Techne Corporation Reports 2% YOY Revenue Growth in Q1 2024 Fiscal Report
US-based life sciences service provider Bio-Techne Corporation (NASDAQ: TECH) has released its Q1 report for...
Finance
AnHeart Therapeutics Signs Exclusive License Deal with Nippon Kayaku for Taletrectinib
China-based AnHeart Therapeutics has announced the signing of an exclusive license deal with Japan-based biopharma...
Amgen Reports Q3 2023 Financials: 5% Growth Driven by Volume Expansion
Amgen (NASDAQ: AMGN) has released its Q3 2023 financial results, showcasing a 5% year-on-year (YOY)...
Danyang Huichuang Secures Over USD 13.7 Million in Series B Funding for fNIRS Development
Danyang Huichuang Medical Equipment Co., Ltd, a China-based specialist in functional near-infrared spectroscopy (fNIRS), has...
AbbVie’s Q3 2023 Report Shows 6.0% YOY Decline in Net Revenues
AbbVie (NYSE: ABBV) released its Q3 2023 financial report last week, revealing a 6.0% year-on-year...
Dr. Reddy’s Laboratories Reports 9% YOY Revenue Growth in Q2 2024 Fiscal Year
India-based generics giant Dr. Reddy’s Laboratories Ltd (NYSE: RDY) has released its financial report for...
Sanofi SA Reports Q3 2023 Financials with Focus on R&D and Dupixent Growth
French pharmaceutical giant Sanofi SA (NASDAQ: SNY) released its Q3 2023 financial results, reporting a...
BMS Revenue Slips Due to Revlimid Erosion: Q3 2023 Insights
Bristol Myers Squibb (BMS; NYSE: BMY) reported a 3% year-on-year (YOY) revenue decline, excluding foreign...
Sonosemi Medical Secures Over USD 27.3 Million in Series B Funding for Vascular Intervention Devices
Sonosemi Medical Co., Ltd., a Shenzhen-based innovator in vascular graft intervention devices, has reportedly secured...
Novartis Q3 Earnings Reflect Strong Growth Post-Sandoz Spinoff
Novartis (NYSE: NVS) has released its Q3 2023 financial results, marking the first report since...
Leadinno Medical Valley Secures Series A+ Funding for Neuroregulation Device R&D
Leadinno Medical Valley, a Beijing-based innovator in pain management and neuroregulation devices, has reportedly secured...
OrbiMed Raises Over USD 4.3 Billion for Private Investment Funds Focused on Healthcare
US-based investment fund giant OrbiMed has announced the successful raising of over USD 4.3 billion...
Changchun BCHT Biotechnology Invests in Influenza Vaccine Production Expansion
China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced plans to invest RMB 805...
CBC HIP Secures USD 875 Million for Life Science Real Assets Venture CLSRA
CBC Healthcare Infrastructure Platform (CBC HIP), a prominent independent life science real assets investor in...
Roche’s Q3 2023 Report Shows 1% Global Growth Amid Lower COVID-19 Product Demand
Swiss pharmaceutical giant Roche (SWX: ROG) released its Q3 2023 report, indicating that a reduced...
AlphaGen Therapeutics Secures Seed Funding for Pb-212 Radioligand Therapy Development
AlphaGen Therapeutics Ltd, a Shanghai-based developer specializing in radioligand therapy (RLT), has reportedly secured “tens...
Pharmaron Beijing to Establish Singapore JV Rxilient Biohub for CDMO Services
China-based Contract Development and Manufacturing Organization (CDMO) Pharmaron Beijing Co., Ltd (HKG: 3759, SHE: 300759)...
Abbott Reports 8.7% Drop in Q3 2023 Global Sales, Hit by Lower SARS-CoV-2 Test Demand
Abbott (NYSE: ABT) published its Q3 2023 financial results this week, reporting a 8.7% year-on-year...
J&J Reports Strong Q3 2023 Sales Growth Amid Diverse Business Performance
Johnson & Johnson (J&J; NYSE: JNJ) has released its Q3 2023 report, revealing impressive global...
Sirius Therapeutics Secures USD 60 Million in Series B Financing for siRNA Therapy Development
Sirius Therapeutics, a Shanghai-based developer of siRNA therapies, has successfully raised USD 60 million in...